Cognito Therapeutics and Aetion Announce Partnership to Use Artificial Intelligence to Identify Rapidly Progressing Forms of Mild Cognitive Impairment and Alzheimer’s Disease
March 08, 2022 08:00 AM Eastern Standard Time CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Cognito Therapeutics, a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, and Aetion, a global real-world evidence...